Anebulo Pharmaceuticals, Inc. (ANEB) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Anebulo Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • Anebulo Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$64.1 M, a 17.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$64.1 M -$9.35 M -17.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$62.4 M -$10.5 M -20.2% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$59.7 M -$11.6 M -24.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$57.2 M -$11.7 M -25.8% Jun 30, 2023 10-Q 2024-05-15
Q1 2023 -$54.7 M -$11.6 M -26.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$51.9 M -$10.6 M -25.8% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 -$48.1 M -$7.88 M -19.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$45.5 M -$6.83 M -17.7% Jun 30, 2022 10-K 2023-09-22
Q1 2022 -$43.1 M -$33.6 M -353% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 -$41.3 M Dec 31, 2021 10-Q 2022-02-11
Q3 2021 -$40.2 M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$38.6 M -$38.5 M -21001% Jun 30, 2021 10-K 2022-09-09
Q1 2021 -$9.53 M Mar 31, 2021 10-Q 2021-06-21
Q2 2020 -$183 K Jun 30, 2020 10-K 2021-09-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.